|Bid||82.18 x 800|
|Ask||82.24 x 800|
|Day's Range||81.25 - 84.85|
|52 Week Range||51.51 - 92.08|
|Beta (5Y Monthly)||1.02|
|PE Ratio (TTM)||63.16|
|Earnings Date||Apr 21, 2021 - Apr 26, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||94.25|
Prices have yet to reach our $104 price target and remain above $79 but we still want to check the charts again. In this updated daily bar chart of EW, below, we can see that prices have been in a choppy sideways pattern since September. The On-Balance-Volume (OBV) line has been declining since the beginning of 2021 and tells us that sellers of EW have been more aggressive.
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...
Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons.